MedTrace Logo

The Use of Ventriject to Assess V02Max in Patients Admitted to Hospital in the Emergency Surgery Setting

NCT06189131 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2025-03-19

No results posted yet for this study

Summary

The aim of this study is to assess whether Ventriject V02Max can provide values in a clinical setting and whether this value correlates with clinical outcome in patients admitted to the emergency general surgery department in a single centre. We will also be assessing the acceptability of the device to patients and clinicians.

Conditions

  • Emergencies
  • Surgery

Interventions

DEVICE

Ventriject

Ventriject is a non-exercise method for estimating V02Max

Sponsors & Collaborators

  • The Leeds Teaching Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Melissa Bautista · Leeds Teaching Hospitals NHS Trust

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-03
Primary Completion
2025-11-11
Completion
2025-11-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06189131 on ClinicalTrials.gov